↓ Read PDF
01 · ABSTRACT

Abstract

Dietary/Nutritional supplements have become popular in use by a spectrum of different consumers, including the elderly, those aged 65 and over, as a ‘new’ market. In the USA, their numbers have been increasing from 35 million in 2000, to a projected 69 million by 2030. Dopamine, serotonin, epinephrine neurotransmitter homeostasis is important in the ‘healthy’ physiological continuum of all ages. Imbalance in these neurotransmitters, over time, manifests in various ‘disease’ states, such as Obsessive Compulsive Disorder, Parkinson’s Disease, and Schizophrenia. In context, dietary/nutritional supplements may contain contaminants/adulterants that could distort the ‘normal’ equilibrium of neurotransmitters. Therefore, for this investigation fluoxetine a Schedule 5 (South Africa) selective serotonin reuptake inhibitor (SSRI) drug was investigated. The extent of fluoxetine as contaminant/adulterant in dietary/nutritional supplements is not widely known. Further, fluoxetine prescriber caution for treatment (elderly), are adverse effects, particular CNS effects, such as nervousness, agitation, anxiety or excessive sedation, and insomnia. The aim of this study was to determine whether commercially available dietary/nutritional and traditional supplement products contained fluoxetine, even though the manufacturer may not declare this on the product label. A total of 138 dietary/nutritional supplements products formed part of the assessment. The products were laboratory analysed for fluoxetine, as part of an extensive multi-compound ‘screen’, using Tandem Liquid Chromatography Mass Spectrometry. The concentration of fluoxetine was then estimated via calibration curve standards that formed part of the extraction and analysis. The number of ‘positives’ for the tested products for fluoxetine in the overall sample was 54%, for South African produced products 67%, and, for imported products, bought in South Africa 56%. The median concentration estimate for fluoxetine in the products were, 3.9 µg/g for the overall sample, 5.2 µg/g for South African produced products, and 20.1 µg/g for imported products, bought in South Africa.

↓ Read PDF
02 · PUBLICATION RECORD

Article details

JournalMedical Research Archives
IssueVol 6 No 2 (2018): Vol.6 Issue 2 February 2018
SectionResearch Articles
Published15 February 2018
DOI10.18103/mra.v6i2.1616
ISSN2375-1924
03 · RIGHTS & REUSE

Rights & reuse

This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.

Authors & affiliations

GG

Gary Gabriels

1. University of Johannesburg, Faculty of Health Science, Gauteng, South Africa; 2. University of the Witwatersrand, Johannesburg, South Africa

PS

Pete Smith

University of Cape Town, Faculty of Health Sciences

YC

Yoga Coopoo

University of Johannesburg, Faculty of Health Science, Gauteng, South Africa

Medical Research Archives

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Start your submission  ↗